Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS: ARDS · Delayed Price · USD
0.0010
-0.0090 (-90.00%)
Jul 25, 2024, 4:00 PM EDT - Market closed
Aridis Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | 2017 - 2015 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.04 | 4.88 | 18.1 | 8.23 | 20.9 | 24.24 | Upgrade
|
| Cash & Short-Term Investments | 0.04 | 4.88 | 18.1 | 8.23 | 20.9 | 24.24 | Upgrade
|
| Cash Growth | -98.14% | -73.06% | 119.85% | -60.61% | -13.78% | -3.42% | Upgrade
|
| Receivables | 0.52 | 1.24 | 0.24 | 0.37 | 0.41 | 2.1 | Upgrade
|
| Prepaid Expenses | 3.56 | 3.34 | 2.7 | 2.18 | 2.99 | 1.56 | Upgrade
|
| Restricted Cash | - | 0.18 | 1.39 | - | - | - | Upgrade
|
| Other Current Assets | - | 1.99 | 1.97 | 1.97 | 1.54 | 0.46 | Upgrade
|
| Total Current Assets | 4.11 | 11.63 | 24.39 | 12.76 | 25.84 | 28.35 | Upgrade
|
| Property, Plant & Equipment | 1.58 | 2.15 | 1.36 | 1.26 | 1.01 | 1.27 | Upgrade
|
| Long-Term Investments | - | - | - | - | 0.01 | 0.96 | Upgrade
|
| Other Intangible Assets | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | Upgrade
|
| Long-Term Deferred Charges | - | 0.08 | 0.1 | 0.09 | 0.53 | - | Upgrade
|
| Other Long-Term Assets | 0.83 | 0.83 | 0.93 | 0.99 | 0.56 | 1 | Upgrade
|
| Total Assets | 6.53 | 14.7 | 26.8 | 15.12 | 27.97 | 31.61 | Upgrade
|
| Accounts Payable | 5.41 | 2.31 | 5.24 | 1.89 | 1.76 | 2.33 | Upgrade
|
| Accrued Expenses | 7.69 | 9.56 | 6.46 | 1.33 | 2.97 | 2.94 | Upgrade
|
| Short-Term Debt | - | 0.52 | 0.7 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 3.41 | 3.78 | - | 0.44 | - | - | Upgrade
|
| Current Portion of Leases | 0.58 | 0.54 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.38 | 20.17 | 20.84 | 18.75 | 14.6 | 0.02 | Upgrade
|
| Other Current Liabilities | 0.02 | 0.02 | 0.11 | 0.04 | - | - | Upgrade
|
| Total Current Liabilities | 17.48 | 36.9 | 33.35 | 22.44 | 19.33 | 5.3 | Upgrade
|
| Long-Term Debt | - | - | 5.28 | 0.28 | - | - | Upgrade
|
| Long-Term Leases | 0.85 | 1.29 | - | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | 0.74 | 0.91 | 0.85 | 5 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.36 | 0.23 | - | - | Upgrade
|
| Total Liabilities | 18.34 | 38.93 | 39.91 | 23.8 | 24.33 | 5.3 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 170.83 | 166.38 | 152.18 | 114.42 | 104.4 | 97.4 | Upgrade
|
| Retained Earnings | -190.42 | -195.67 | -165.3 | -123.1 | -100.77 | -71.09 | Upgrade
|
| Comprensive Income & Other | 7.79 | 5.05 | - | - | - | - | Upgrade
|
| Total Common Equity | -11.8 | -24.23 | -13.11 | -8.68 | 3.64 | 26.31 | Upgrade
|
| Shareholders' Equity | -11.8 | -24.23 | -13.11 | -8.68 | 3.64 | 26.31 | Upgrade
|
| Total Liabilities & Equity | 6.53 | 14.7 | 26.8 | 15.12 | 27.97 | 31.61 | Upgrade
|
| Total Debt | 4.84 | 6.13 | 5.98 | 0.72 | - | - | Upgrade
|
| Net Cash (Debt) | -4.81 | -1.25 | 12.12 | 7.52 | 20.9 | 24.24 | Upgrade
|
| Net Cash Growth | - | - | 61.23% | -64.03% | -13.78% | -3.42% | Upgrade
|
| Net Cash Per Share | -0.15 | -0.07 | 0.99 | 0.82 | 2.47 | 7.70 | Upgrade
|
| Filing Date Shares Outstanding | 44.57 | 36.08 | 17.7 | 11.23 | 8.92 | 8.11 | Upgrade
|
| Total Common Shares Outstanding | 44.57 | 27.03 | 17.7 | 10.07 | 8.92 | 8.1 | Upgrade
|
| Working Capital | -13.37 | -25.27 | -8.96 | -9.69 | 6.51 | 23.05 | Upgrade
|
| Book Value Per Share | -0.26 | -0.90 | -0.74 | -0.86 | 0.41 | 3.25 | Upgrade
|
| Tangible Book Value | -11.82 | -24.25 | -13.13 | -8.71 | 3.6 | 26.28 | Upgrade
|
| Tangible Book Value Per Share | -0.27 | -0.90 | -0.74 | -0.87 | 0.40 | 3.24 | Upgrade
|
| Machinery | 2.23 | 2.25 | 2.42 | 2.23 | 1.83 | 1.76 | Upgrade
|
| Construction In Progress | - | - | - | 0.19 | - | - | Upgrade
|
| Leasehold Improvements | 0.53 | 0.53 | 0.53 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template.